Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Every year, approximately 3 to 5 of 100.000 people are newly diagnosed with a glioblastoma (GBM). The current standard of care is the surgical resection, radiotherapy and chemotherapy. However, despite this aggressive treatment, the median survival time is only 12 to 15 months after initial diagnosis. Patients with recurrent disease normally have a life expectancy of only a few weeks.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi